Improving treatment decisions in inflammatory bowel disease with validated and standardised microbiome analysis

Forschungsstelle

INNOSUISSE

Projektnummer

119.930 IP-LS

Projekttitel

Improving treatment decisions in inflammatory bowel disease with validated and standardised microbiome analysis

Projekttitel Englisch

Improving treatment decisions in inflammatory bowel disease with validated and standardised microbiome analysis

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Human medicine
Abstract (Englisch)	We will set a new gold standard in microbiome analysis by extending the current 16S approach and CALEX® device-based automation. Advancing to better species resolution and activity assessment through metabolomics, new combined databases will lead to more profound therapeutic decisions e.g. in IBD.